Pharma market rebounds, asthma drug top seller

India's pharmaceutical retail market rebounded in November with double-digit growth, driven by increased demand for dermatological and cardiac medications. Respiratory issues, exacerbated by pollution, boosted Foracort sales to Rs 82 crore. Both acute and chronic medications saw 11% growth, and industry volumes rose by 3.5%. Analysts predict continued growth in 2025, fueled by price increases and new drug launches.

Pharma market rebounds, asthma drug top seller

Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -

Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -

India's pharmaceutical retail market rebounded in November with double-digit growth, driven by increased demand for dermatological and cardiac medications. Respiratory issues, exacerbated by pollution, boosted Foracort sales to Rs 82 crore. Both acute and chronic medications saw 11% growth, and industry volumes rose by 3.5%. Analysts predict continued growth in 2025, fueled by price increases and new drug launches.